Abstract
Filippatos G, Butler J, Farmakis D, et al. Empagliflozin for heart failure with preserved left ventricular ejection fraction with and without diabetes. Circulation. 2022;146:676-86. 35762322.
MeSH terms
-
Benzhydryl Compounds
-
Diabetes Mellitus* / drug therapy
-
Glucosides
-
Heart Failure* / drug therapy
-
Hospitalization
-
Humans
-
Stroke Volume
-
Ventricular Function, Left
Substances
-
Benzhydryl Compounds
-
Glucosides
-
empagliflozin